Date:- April 14-19, 2023
Location:- Orlando, Florida
Join us at the AACR Annual Meeting 2023 to learn more about how Veracyte’s Biopharma Services offerings can help you move your oncology and immuno-oncology drug development programs forward with confidence. We invite you to book an in-person meeting in advance (schedule a meeting here) or connect with us in Orlando at any of the following:
- Attend our Spotlight Theater on Sunday, April 16th, 3:30-4:30 PM ET, “Leveraging multi-omics insights to advance drug development programs”. Meet our speakers from Veracyte (Jérôme Galon, PhD, Senior VP and Scientific Executive Director Veracyte, Corinne Danan, General Manager, Biopharma Services at Veracyte, Jacques Fieschi, PhD, VP, Research Discovery at Veracyte) and users of our services who will share how Decipher GRID Real-World Data, Biopharma Atlas and Immunogram can help guide your drug development programs.
book you seat today
- Visit our poster presentations featuring several of our technologies:
- Deciphering the tumor microenvironment at single-cell resolution using a workflow combining RNA transcript and protein detection with Brightplex®, a sequential chromogenic multiplex assay.
Presenter: Jacques Fieschi, Ph.D., Veracyte
Date/Time: Tuesday, April 18, 1:30-5:00 p.m. ET
Location: Poster Section 4 (Poster #14, Abstract #4624)
- Veracyte Biopharma Atlas for colorectal cancer: combining multi-parameter approach and machine learning to capture the complexity of the tumor immune contexture.
Presenter: Florence Monville, Ph.D., Research Discovery, Veracyte
Date/Time: Tuesday, April 18, 1:30-5:00 p.m. ET
Location: Poster Section 37 (Poster #26, Abstract #5476)
- Defining the cancer Immunogram using multimodal analysis to guide immunotherapy in diffuse large B cell lymphoma.
Presenter: Régis Perbost, Ph.D., Veracyte and Mike Mattie, Ph.D., Kite a Gilead company
Date/Time: Wednesday, April 19, 9:00 a.m.-12:30 p.m. ET
Location: Poster Section 4 (Poster #21, Abstract #5879)
- Deciphering the tumor microenvironment at single-cell resolution using a workflow combining RNA transcript and protein detection with Brightplex®, a sequential chromogenic multiplex assay.
- Speak with a Biopharma Services team member at Booth #1701